HALOZYME THERAPEUTICS, INC. (HALO) Reports Material Event to SEC
Filing Details HALOZYME THERAPEUTICS, INC. (NASDAQ:HALO) filed a Form 8-K with the Securities and Exchange Commission on July 02, 2026, disclosing a material event. Market Context…
Read more
